Minerva Neurosciences (NERV) Non-Current Deferred Tax Liability (2013 - 2021)

Minerva Neurosciences (NERV) has 9 years of Non-Current Deferred Tax Liability data on file, last reported at $1.8 million in Q3 2021.

• Quarterly Non-Current Deferred Tax Liability changed 0.0% year-over-year to $1.8 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $1.8 million (changed 0.0% YoY) and the FY2020 annual result came in at $1.8 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability steadied at $1.8 million in Q3 2021, from $1.8 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $13.4 million in Q1 2017 to a low of $1.8 million in Q4 2019.
• A 5-year average of $4.6 million and a median of $4.1 million in 2017 frame the typical range for Non-Current Deferred Tax Liability.
• The widest YoY moves for Non-Current Deferred Tax Liability: up 0.0% in 2017, down 69.8% in 2017.
• Tracing NERV's Non-Current Deferred Tax Liability over 5 years: stood at $4.1 million in 2017, then changed by 0.0% to $4.1 million in 2018, then slumped by 55.55% to $1.8 million in 2019, then changed by 0.0% to $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021.
• The last three Non-Current Deferred Tax Liability figures came in at $1.8 million (Q3 2021), $1.8 million (Q2 2021), and $1.8 million (Q1 2021), per Business Quant data.